Target intelligence / Profile preview

PYCARD antisense RNA 1 (PYCARD-AS1)

Target
PYCARD-AS1
Molecular classification
long noncoding RNA (lncRNA), antisense RNA, Other
01

Overview

PYCARD-AS1 is a long noncoding RNA (lncRNA) transcribed from the opposite strand of the pro-apoptotic gene PYCARD, with dual nuclear and cytoplasmic localization. Mechanistically, PYCARD-AS1 is a key negative regulator of PYCARD, controlling its expression at both epigenetic and translational levels. In the nucleus, PYCARD-AS1 recruits the DNMT1/G9a methylation complex to the PYCARD promoter, facilitating DNA methylation and histone modification, leading to transcriptional silencing. In the cytoplasm, it interacts with PYCARD mRNA to inhibit ribosome assembly, suppressing PYCARD translation. Through coordinated regulation of PYCARD, PYCARD-AS1 influences apoptosis, with implications in cancer biology, notably breast cancer. There are no known drugs targeting PYCARD-AS1 or safety concerns specifically associated with its modulation[1][2][3].

Other names
C16orf98PYCARDOSPutative uncharacterized protein PYCARD-AS1PYCARD antisense gene protein 1PYCARD opposite strand proteinPYCARD opposite strand
02

Mechanism of action

PYCARD-AS1 recruits DNA methyltransferase 1 (DNMT1) and histone methyltransferase G9a to the PYCARD promoter, promoting gene silencing through DNA and histone modification. It also engages in RNA-RNA interaction with PYCARD mRNA, interfering with ribosome assembly and suppressing translation.

03

Biological functions

Negative regulation of PYCARD expressionEpigenetic regulation of gene transcription (promoter DNA methylation, histone H3K9 methylation)Inhibition of mRNA translation (ribosome assembly interference)Regulation of apoptosis (via PYCARD)
04

Disease associations

Cancer (specifically breast cancer, through regulation of PYCARD-mediated apoptosis)
05

Biomarkers

Expression level of PYCARD-AS1 may serve as a biomarker for epigenetic status and silencing of PYCARD in cancers

Beyond the preview

Go deeper on PYCARD antisense RNA 1 (PYCARD-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PYCARD antisense RNA 1 (PYCARD-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call